ImmuCell Corporation
ICCC
$5.25
$0.255.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 160.98% | 143.51% | 93.03% | 62.65% | 39.53% |
| Total Depreciation and Amortization | 0.33% | -0.76% | -1.15% | -1.10% | 1.58% |
| Total Amortization of Deferred Charges | 47.97% | 8.54% | 39.81% | 88.50% | 190.97% |
| Total Other Non-Cash Items | -107.86% | -70.65% | -58.70% | -59.55% | -44.06% |
| Change in Net Operating Assets | -768.97% | -404.25% | -47.85% | 80.75% | 122.18% |
| Cash from Operations | 649.46% | 1,198.40% | 201.30% | 107.66% | 93.10% |
| Capital Expenditure | -263.28% | -12.59% | 43.44% | 75.39% | 89.37% |
| Sale of Property, Plant, and Equipment | 591.11% | 323.19% | 80.00% | 80.00% | 80.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Investing | -437.72% | -9.39% | 43.68% | 75.60% | 93.23% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -55.75% | 55.87% | 54.88% | 53.91% | 52.85% |
| Issuance of Common Stock | -71.79% | 1,012.60% | 26,193.09% | 26,089.89% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.78% | -87.23% | -605.66% | -602.33% | -169.11% |
| Cash from Financing | -127.72% | 270.93% | 347.17% | 64.60% | 32.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.74% | 3,695.46% | 270.39% | 157.75% | 126.60% |